Between February and May 2020, during the first wave of the COVID-19 pandemic, we sent out a survey to all European paediatric sites within the Penta ID research network. The aim of the study was to describe the implementation of SARS-CoV-2 disease (COVID-19) testing and infection control strategies, and their evolution in paediatric emergency departments in Europe.
Although infection control strategies and even discharge of patients relied heavily on receiving SARS-CoV-2 test results,
The first international symposium focusing on Varicella-Zoster will be held 12-14 March in Athens, Greece.
This meeting will bring together experts working across public health institutions, to summarise the current state of the art knowledge on prevention of Varicella Zoster infections. Offering the opportunity for experts to share their experiences on Universal Varicella Vaccination programmes and discus challenges for further implementation, knowledge gaps and ways to overcome the remaining barriers to move varicella forward as a truly vaccine preventable disease.
The first edition of the Global Health Festival (‘Festival della Salute Globale’) is to take place in Padova, Italy on 5th-7thApril 2019. In partnership with Comune di Padova, Università degli Studi di Padova and Medici con l’Africa CUAMM,
Although the number of new HIV infections has continued to decline globally, and the overall level of HIV treatment is high, progress is far slower than what is required to reach the 2020 milestone of less than 500,000 new infections.
Children remain a vulnerable population, with 2017 witnessing 180,000 new cases of children becoming infected with HIV – a long way off the proposed target, set by the United Nations,
Authors: Donà D, Luise D, Da Dalt L, Giaquinto C.
Published in: Int J Pediatr; 2017: 4239268.
Abstract: Background. Pneumonia represents an important threat to children’s health in both developed and developing countries. In the last 10 years, many national and international guidelines on the treatment of pediatric CAP have been published,
Authors: Writing group for the Kids to Adults Working Group and Data Management and Harmonisation Group in EuroCoord.
Published in: Euro Surveill.2016;21(10): 30162
Abstract Accurate ascertainment of the number of children living with human immunodeficiency virus (HIV) is important to plan paediatric and adolescent health services. In Europe, the first generation of perinatally HIV-infected survivors are transferring to adult care and their health needs are unknown.
Authors: Antinori A., Marcotullio S., Andreoni M., Ammassari A., d’Arminio Monforte A., Galli M., Girardi E., Mazzotta F., Mussini C., Puoti M., Lazzarin A.; Italian HIV Guidelines Working Group.
Published in: New Microbiol. 2015, 38: 299-328
Abstract: This short version complies with the intention expressed in the introduction to the full text Italian Guidelines for the use of antiretroviral drugs and the diagnostic-clinical management of people with HIV-1 infection.
Authors: De Bie S., Ferrajolo C., Straus S.M., Verhamme K.M., Bonhoeffer J., Wong I.C., Sturkenboom M.C., GRiP network
Published in: PLoS One. 2015, 10: 0130399.
Abstract: Individual case safety reports (ICSRs) are a cornerstone in drug safety surveillance. The knowledge on using these data specifically for children is limited. We studied characteristics of pediatric ICSRs reported to the US Food and Drug Administration (FDA) Adverse Event Reporting System (FAERS).
Authors: European Collaborative Study in Eurocord
Published in: Antivir Ther, 2011,16: 859-903.
Background: Although mother-to-child transmission (MTCT) rates are at an all-time low in Western Europe, potentially preventable transmissions continue to occur. Duration of antenatal combination antiretroviral therapy (ART) is strongly associated with MTCT risk.
Methods: Data on pregnant HIV-infected women enrolled in the Western and Central European sites of the European Collaborative Study between January 2000 and July 2009 were analysed.
Authors: Antinori A., Marcotullio S., Ammassari A., Andreoni M., Angarano G., Armignacco O., Carosi G., Cinque P., d’Arminio Monforte A., Di Perri G., Ensoli B., Florida M., Galli M., Mastroianni C., Matteelli A., Mazzotta F., Moroni M., Pal G., Puoti M., Puro V., Rizzardini G., Sagnelli E., Vella S., Vullo V., Lazzarin A., Italian HIV Guidelines Working Group (Giaquinto C. member of Study Group)
Published in: New Microbiol 2012,
Authors: Chiappini E., Galli L., Tovo P.A., Gabiano C., Lisi C., Giacomet V., Bernardi S., Esposito S., Rosso R., Giaquinto C ., Badolato R., Guarino A., Maccabruni A., Masi M., Cellini M., Salvini F., Di Bari C., Dedoni M., Dodi I., De Martino M for the Italian Register for HIV infection in children
Published in: Acta Paediatr, 2012, 101: 287-295
Background: Information on the use of new antiretroviral drugs in children in the real setting of clinical fields is largely unknown.
Authors: Alam N., Cortina – Borja M., Goetghebuer T., et al. European Paediatr HIV & Lipodystrop (Giaquinto C. member of the Study Group)
Published in: JAIDS, 2012, 59: 314 – 32
Objectives: To estimate the prevalence of and identify risk factors for lipodystrophy syndrome (LS) and body fat abnormality in a population of HIV-infected children and adolescents.